Livzon Pharmaceutical Group discloses A-share buyback on Shenzhen Stock Exchange

Livzon Pharmaceutical Group announced its share repurchase activities in a next day disclosure report dated September 26, 2025. On that date, the company repurchased 130,800 A shares through the Shenzhen Stock Exchange.

The average repurchase price for these shares ranged from RMB 37.99 to RMB 38.46, totaling RMB 4,997,939. These 130,800 A shares are intended to be canceled, with zero held as treasury stock.

Before this latest repurchase, the company's total issued A shares stood at 604,293,313 as of September 25, 2025. Following the September 26, 2025 repurchase, the total issued A shares remained unchanged. For its H shares, the company reported 299,807,117 issued shares as of September 25, 2025, with no reported repurchases on September 26, 2025.

The report also detailed numerous A-share repurchases throughout late 2024 and 2025, including 558,400 A shares on February 13, 2025, at RMB 35.81, and 561,400 A shares on January 14, 2025, at RMB 35.62, showcasing a continuous effort in managing its capital structure.